Biomeme's platform transforms your smartphone into a mobile lab for advanced DNA diagnostics and real-time disease surveillance. The system includes a docking station for real-time qPCR, a mobile app to control the system and analyze results, and targeted test kits for preparing samples and identifying pathogens or diseases by their specific DNA or RNA signatures. The cutting edge platform performs to the gold standard used by the world's most advanced central labs but requires no lab equipment or special experience to use.
The low-cost, user-friendly system enables mobile testing at the point-of-need for health care (mobile clinics, disease tracking, home use), agriculture (plant disease tracking, food safety), vector surveillance (Malaria, West Nile mosquitos), veterinary medicine, environmental monitoring (soil and water safety), and even education and citizen science.
The low-cost, user-friendly system enables mobile testing at the point-of-need for health care (mobile clinics, disease tracking, home use), agriculture (plant disease tracking, food safety), vector surveillance (Malaria, West Nile mosquitos), veterinary medicine, environmental monitoring (soil and water safety), and even education and citizen science.
Location: United States, Pennsylvania, Philadelphia
Employees: 51-200
Total raised: $21M
Founded date: 2012
Investors 6
| Date | Name | Website |
| 09.07.2021 | Robin Hood... | robinhoodv... |
| - | DreamIt Ve... | dreamit.co... |
| - | Nextfab | nextfab.co... |
| - | Future Com... | futurecomm... |
| - | Ben Frankl... | sep.benfra... |
| - | Darco Capi... | darcocapit... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 20.12.2021 | - | $21M | - |
Mentions in press and media 20
| Date | Title | Description |
| 20.07.2023 | Biomeme Collaborates with NIH-funded Antibacterial Resistance Leadership Group to Evaluate Host Response Test, Differentiating Bacterial & Viral Infections to Combat AMR | AMR is a systemic and global problem of huge proportions against which progress has been stalled during COVID-19. Creating preventative approaches to promote prudent antimicrobial use through a One Health approach is imperative to addressin... |
| 05.06.2023 | Prestigious Award for Life Sciences & Healthcare Emerging 2023 | We are honored to receive this award,” said Max Perelman, CEO at Biomeme. Since our founding in 2012, we've gone from our first prototype PCR thermocycler using a travel hair dryer and an iPhone 4 to being a leading biotechnology companies ... |
| 20.03.2023 | Biomeme Supports Biosecurity Surveillance Program Launched by Ginkgo Bioworks and the Ukraine Ministry of Health | Our partnership with Concentric by Ginkgo continues to strengthen because of our alignment and focus on Biosecurity. We share in their belief that a “biosecurity in a box” model could be a way to manage biosecurity concerns in crisis zones,... |
| 09.09.2021 | Biomeme Appoints Ephraim Tsalik, MD, PhD as Chief Medical Officer | Ephraim Tsalik, Chief Medical Officer at Biomeme, Inc Our team is focused on developing revolutionary point-of-care technology to better diagnose and manage disease. Together with the Biomeme team, I will leverage my experience to deliver o... |
| 26.08.2021 | Biomeme & Predigen Merge to Enable Point-of-Care Delivery of Host Response Tests That Address Critical Unmet Needs in Healthcare | Predigen and Biomeme Host Response Test System (HR-BV) PHILADELPHIA (PRWEB) August 26, 2021 Biomeme, the leading provider of portable PCR testing solutions, has signed a definitive agreement to acquire Predigen, a privately held diagnostic ... |
| 05.04.2021 | After a pandemic growth spurt, COVID-19 test maker Biomeme is moving its HQ to North Broad and looking to the future | About this time last year, Biomeme — makers of a rapid COVID-19 test and other diagnostic hardware — had about 35 people in its 10th and Chestnut streets HQ. Enter a global pandemic. The company, now about 280 employees across the U.S. and ... |
| 31.03.2021 | Biomeme & One Health Labs Announce Partnership with Ginkgo Bioworks to Address National Pandemic with Pooled Testing at K-12 Schools | Student self collecting swab sample As communities across America work to accomplish the national priority of returning to in-person learning over the coming months, testing will be a critical tool to monitor viral spread and build confiden... |
| 10.12.2020 | What’s coming up at MedCity INVEST Precision Medicine Day 3? | The MedCity INVEST Precision Medicine healthcare conference on December 9-11 draws healthcare and life science executives and investors as we spotlight progress in the development of diagnostics, clinical trial innovation, AI in drug develo... |
| 08.12.2020 | Which startups will present at MedCity INVEST Precision Medicine Pitch Perfect? | The MedCity INVEST Precision Medicine healthcare conference on December 9-11 will draw healthcare and life science executives as we spotlight progress in the development of diagnostics, clinical trial innovation, AI in drug development, and... |
| 09.07.2018 | CONVERGE Preview: Investment in screening tools as one approach to supporting cancer treatment innovation | In a Q&A, Griffith-Gryga highlighted some of the Dreamit companies that could make an impact on cancer care. Note: This exchange has been lightly edited. How did you come to work for Dreamit Ventures? I had been a VC for 14 years when I... |
Show more